Cargando…
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis
BACKGROUND: The toll-like receptor 4 (TLR4) agonist, Bacille Calmette-Guérin, has exhibited gratifying effects in treating bladder cancer. The study aims to explore the expression pattern, prognostic value, and potential mechanism of TLR4 in bladder cancer. METHODS: The transcriptome file from the G...
Autores principales: | Lu, Jun-Lin, Xia, Qi-Dong, Sun, Yi, Xun, Yang, Hu, Heng-Long, Liu, Chen-Qian, Sun, Jian-Xuan, Xu, Jin-Zhou, Hu, Jia, Wang, Shao-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204102/ https://www.ncbi.nlm.nih.gov/pubmed/34141706 http://dx.doi.org/10.3389/fcell.2021.651560 |
Ejemplares similares
-
Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022) -
Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
por: Hu, Rixin, et al.
Publicado: (2022) -
Multi-Omics Characterization of Circular RNA-Encoded Novel Proteins Associated With Bladder Outlet Obstruction
por: Zhu, Baoyi, et al.
Publicado: (2022) -
Single Cell Multi-Omics Technology: Methodology and Application
por: Hu, Youjin, et al.
Publicado: (2018) -
Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)